To enhance our understanding of the role of CD8 + T lymphocytes in AD, Unger et al. conducted a study to investigate the effects of depleting CD8+ T lymphocytes using an anti-CD8a antibody in the APP/PS1 mouse model. This evidence concerns the gene APP and Alzheimer disease.